ACE2 and COVID-19: The rationale for looking at the timing of COVID-19 infection stems from reports showing the possibility of the placenta being affected due to maternal infection, attributed to the expression of the COVID-19 target angiotensin receptor enzyme 2 (ACE2) in the placenta [19].